{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:45:06Z","timestamp":1774791906632,"version":"3.50.1"},"reference-count":47,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-15-00304"],"award-info":[{"award-number":["22-15-00304"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Glioblastoma multiforme (GBM) accounts for almost half of all primary malignant brain tumors in adults and has a poor prognosis. Here we demonstrated the oncolytic potential of the L-16 vaccine strain of measles virus (MV) against primary human GBM cells and characterized the genetic patterns that determine the sensitivity of primary human GBM cells to oncolytic therapy. MV replicated in all GBM cells, and seven out of eight cell lines underwent complete or partial oncolysis. RNA-Seq analysis identified about 1200 differentially expressed genes (FDR &lt; 0.05) with at least two-fold expression level change between MV-infected and uninfected cells. Among them, the most significant upregulation was observed for interferon response, apoptosis and cytokine signaling. One out of eight GBM cell lines was defective in type I interferon production and, thus, in the post-interferon response, other cells lacked expression of different cellular defense factors. Thus, none of the cell lines displayed induction of the total gene set necessary for effective inhibition of MV replication. In the resistant cells, we detected aberrant expression of metalloproteinase genes, particularly MMP3. Thus, such genes could be considered intriguing candidates for further study of factors responsible for cell sensitivity and resistance to L-16 MV infection.<\/jats:p>","DOI":"10.3390\/v14112433","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T04:11:31Z","timestamp":1667448691000},"page":"2433","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Transcriptome Analysis of Human Glioblastoma Cells Susceptible to Infection with the Leningrad-16 Vaccine Strain of Measles Virus"],"prefix":"10.3390","volume":"14","author":[{"given":"Yulia","family":"Ammour","sequence":"first","affiliation":[{"name":"I.I. Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia"},{"name":"Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 119991 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Susova","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation, 115478 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6493-8378","authenticated-orcid":false,"given":"George","family":"Krasnov","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 119991 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Nikolaeva","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vyacheslav","family":"Varachev","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 119991 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia","family":"Schetinina","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Gavrilova","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Mitrofanov","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation, 115478 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Poletaeva","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation, 115478 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Bekyashev","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation, 115478 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny","family":"Faizuloev","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly V.","family":"Zverev","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia"},{"name":"Department of Microbiology, Virology and Immunology of the Medical and Preventive Faculty, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 119146 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oxana A.","family":"Svitich","sequence":"additional","affiliation":[{"name":"I.I. Mechnikov Research Institute for Vaccines and Sera, 105064 Moscow, Russia"},{"name":"Department of Microbiology, Virology and Immunology of the Medical and Preventive Faculty, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 119146 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-4202","authenticated-orcid":false,"given":"Tatiana V.","family":"Nasedkina","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 119991 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fonc.2019.00963","article-title":"Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets","volume":"9","author":"Taylor","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.semcancer.2006.04.002","article-title":"Glioma stem cells: Evidence and limitation","volume":"17","author":"Fan","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"24535","DOI":"10.1021\/acsomega.1c02991","article-title":"The Big Picture of Glioblastoma Malignancy: A Meta-Analysis of Glioblastoma Proteomics to Identify Altered Biological Pathways","volume":"6","author":"Tribe","year":"2021","journal-title":"ACS Omega"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1470-2045(01)00618-0","article-title":"Oncolytic biotherapy: A novel therapeutic plafform","volume":"3","author":"Hawkins","year":"2002","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fcimb.2012.00168","article-title":"Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination","volume":"2","author":"Jounai","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cytogfr.2020.07.009","article-title":"Mechanisms of measles virus oncolytic immunotherapy","volume":"56","author":"Engeland","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/0008-5472.CAN-11-2788","article-title":"Oncolytic Virus and Anti\u20134-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer","volume":"72","author":"John","year":"2012","journal-title":"Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1586\/14737140.8.10.1581","article-title":"Oncolytic viruses: A novel form of immunotherapy","volume":"8","author":"Prestwich","year":"2008","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Suryawanshi, Y.R., and Schulze, A.J. (2021). Oncolytic Viruses for Malignant Glioma: On the Verge of Success?. Viruses, 13.","DOI":"10.20944\/preprints202105.0007.v1"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omto.2022.05.008","article-title":"An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition","volume":"26","author":"Sun","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/neuonc\/noq057","article-title":"Treatment of medulloblastoma with a modified measles virus","volume":"12","author":"Studebaker","year":"2010","journal-title":"Neuro-Oncology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1568009617666170222125035","article-title":"Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects","volume":"18","author":"Msaouel","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/gt.2012.62","article-title":"Oncolytic measles virus strains have significant antitumor activity against glioma stem cells","volume":"20","author":"Allen","year":"2013","journal-title":"Gene Ther."},{"key":"ref_17","first-page":"1101","article-title":"Measles vaccine strains for virotherapy of non-small-cell lung carcinoma","volume":"9","author":"Patel","year":"2014","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ammour, Y., Ryabaya, O., Shchetinina, Y., Prokofeva, E., Gavrilova, M., Khochenkov, D., Vorobyev, D., Faizuloev, E., Shohin, I., and Zverev, V.V. (2020). The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus. Viruses, 12.","DOI":"10.3390\/v12020173"},{"key":"ref_19","first-page":"86","article-title":"[History of purification, attenuation and testing a measles vaccine made from the strain \u201cLeningrad-16\u201d (L-16)]","volume":"67","author":"Smorodintsev","year":"1992","journal-title":"Tr. Inst. Im. Pastera"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S519","DOI":"10.1016\/j.annonc.2021.08.014","article-title":"350P Molecular profiling of tumor tissue and tumor-derived cell lines in patients with glioblastoma","volume":"32","author":"Nasedkina","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jviromet.2012.09.011","article-title":"Quantification of measles, mumps and rubella viruses using real-time quantitative TaqMan-based RT-PCR assay","volume":"187","author":"Ammour","year":"2013","journal-title":"J. Virol. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","article-title":"High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus","volume":"64","author":"Anderson","year":"2004","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3770","article-title":"Going viral with cancer immunotherapy","volume":"14","author":"Lichty","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Qin, Y., and Chen, M. (2016). Host-Pathogen Interactions in Measles Virus Replication and Anti-Viral Immunity. Viruses, 8.","DOI":"10.3390\/v8110308"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2011.11.001","article-title":"Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis","volume":"316","author":"Zhu","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of immunotherapy resistance: Lessons from glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coviro.2020.07.016","article-title":"Measles virus in cancer therapy","volume":"41","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ph6121475","article-title":"Glioblastoma multiforme therapy and mechanisms of resistance","volume":"6","author":"Ramirez","year":"2013","journal-title":"Pharmaceuticals"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"109673","DOI":"10.1016\/j.celrep.2021.109673","article-title":"Viral targeting of glioblastoma stem cells with patient-specific genetic and post-translational p53 deregulations","volume":"36","author":"Almendral","year":"2021","journal-title":"Cell Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1182\/bloodadvances.2018025106","article-title":"p53 regulates CD46 expression and measles virus infection in myeloma cells","volume":"11","author":"Lok","year":"2018","journal-title":"Blood Adv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1134\/S0026893318040027","article-title":"Oncolytic Properties of a Mumps Virus Vaccine Strain in Human Melanoma Cell Lines","volume":"52","author":"Ammour","year":"2018","journal-title":"Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"44892","DOI":"10.18632\/oncotarget.6285","article-title":"Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response","volume":"6","author":"Achard","year":"2015","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2174\/1566523217666170102110502","article-title":"Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus","volume":"16","author":"Allagui","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ymthe.2020.01.027","article-title":"Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus","volume":"28","author":"Aref","year":"2020","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnci\/djy033","article-title":"Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy","volume":"110","author":"Kurokawa","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.omto.2018.12.010","article-title":"Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma","volume":"12","author":"Rajaraman","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virusres.2019.01.014","article-title":"A key anti-viral protein, RSAD2\/VIPERIN, restricts the release of measles virus from infected cells","volume":"263","author":"Kurokawa","year":"2019","journal-title":"Virus Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e00826-19","DOI":"10.1128\/mBio.00826-19","article-title":"Comparative Loss-of-Function Screens Reveal ABCE1 as an Essential Cellular Host Factor for Efficient Translation of Paramyxoviridae and Pneumoviridae","volume":"10","author":"Anderson","year":"2019","journal-title":"mBio"},{"key":"ref_39","first-page":"827","article-title":"Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus","volume":"15","author":"Delaunay","year":"2020","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Nguyen, H.S., Shabani, S., Awad, A.J., Kaushal, M., and Doan, N. (2018). Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061765"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.virol.2013.11.039","article-title":"Sphingosine kinase 1 regulates measles virus replication","volume":"450-451","author":"Vijayan","year":"2014","journal-title":"Virology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1158\/0008-5472.CAN-06-0538","article-title":"Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases","volume":"66","author":"Springfeld","year":"2006","journal-title":"Cancer Res"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"ref_44","first-page":"1475","article-title":"Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients","volume":"29","author":"Grandin","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_45","first-page":"13","article-title":"Current insights into matrix metalloproteinases and glioma progression: Transcending the degradation boundary","volume":"5","author":"Pullen","year":"2018","journal-title":"Met. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1158\/0008-5472.CAN-09-4650","article-title":"Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virus","volume":"70","author":"Schaser","year":"2010","journal-title":"Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.omto.2019.10.004","article-title":"High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of Potency","volume":"15","author":"Hanauer","year":"2019","journal-title":"Mol. Ther. Oncolytics"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/11\/2433\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:09:14Z","timestamp":1760144954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/11\/2433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["v14112433"],"URL":"https:\/\/doi.org\/10.3390\/v14112433","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]}}}